If patients receive GLP1 medications outside their primary health system (for example, from telehealth) or change providers during the treatment, the EHR data collected in our study may not capture the full course of treatment, and this may explain our observation of generally shorter treatment durations, and hence less weight loss, recorded in EHRs
About the Authors Jordan Feigenbaum, MD Jordan Feigenbaum, Founder of Barbell Medicine, has an academic background including a Bachelor of Science in Biology, Master of Science in Anatomy and Physiology, and Doctor of Medicine
Early and ongoing monitoring of blood glucose, INR levels, and other relevant markers can help identify and address potential issues early on
But if youre taking a GLP-1, its worth knowing what that looks like so you can flag concerns to your doctor